AstraZeneca Case Rewards Two Whistleblowers With $45 Million
Blowing the whistle on drugmakers is becoming a habit for a salesman and a psychiatrist splitting a $45 million award after AstraZeneca Plc settled claims of illegally marketing a schizophrenia drug.
